Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, Loehr A, Simmons A, Grivas P, Chowdhury S (2018)
Publication Type: Conference contribution
Publication year: 2018
Book Volume: 41
Pages Range: 324-324
DOI: 10.1093/annonc/mdy283.137
APA:
Feyerabend, S., Boegemann, M., Goebell, P., Stoeckle, M., Nepert, D., Wride, K.,... Chowdhury, S. (2018). ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma. (pp. 324-324).
MLA:
Feyerabend, S., et al. "ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma." 2018. 324-324.
BibTeX: Download